Chongming Zheng

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University · ORCID：0000-0002-2698-463X

发表论文 21 篇 · 总被引 253 次 · h-index 7

代表论文

Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control study (2022 · Liver International · 被引 109)
Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma (2022 · Journal of Cachexia Sarcopenia and Muscle · 被引 56)
Gut microbiome as a biomarker for predicting early recurrence of HBV ‐related hepatocellular carcinoma (2023 · Cancer Science · 被引 32)
Association of glucose-lowering drug target and risk of gastrointestinal cancer: a mendelian randomization study (2024 · Cell & Bioscience · 被引 19)
Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma (2021 · BMC Cancer · 被引 11)
Vericiguat enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction through microRNA-1180-3p/ETS1 pathway (2024 · Cellular Signalling · 被引 9)